Charlson comorbidity index predicts early mortality and overall survival in acute promyelocytic leukemia

Authors

Prajwal Dhakal, Department of Internal Medicine, Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA, USA.
Elizabeth Lyden, Department of Biostatics, University of Nebraska Medical Center, Omaha, NE, USA.
Utsav Joshi, Rochester Regional HealthFollow
Avantika Pyakuryal, Nobel College, Pokhara University, Kathmandu, Nepal.
Krishna Gundabolu, Department of Internal Medicine, Division of Oncology and Hematology, University of Nebraska Medical Center, Omaha, NE, USA; Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA.
Vijaya Raj Bhatt, Department of Internal Medicine, Division of Oncology and Hematology, University of Nebraska Medical Center, Omaha, NE, USA; Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA.

Department

Internal Medicine

Document Type

Article

Publication Title

Leukemia Research

First Page

106927

DOI

10.1016/j.leukres.2022.106927

Volume

122

Publication Date

11-1-2022

PubMed ID

36087366

Recommended Citation

Dhakal, P., Lyden, E., Joshi, U., Pyakuryal, A., Gundabolu, K., & Bhatt, V. R. (2022). Charlson comorbidity index predicts early mortality and overall survival in acute promyelocytic leukemia. Leukemia Research, 122, 106927. https://doi.org/10.1016/j.leukres.2022.106927